There were numerous reports investigating the association of leptin or leptin receptors mRNA expression with the risk of various cancers either by immunohistochemical techniques or by RT‐PCR (as this study); however, fewer studies have been conducted on prostate cancer. The gene discussed is LEPR; the disease is prostate carcinoma.